Loading patent…
AssigneesOptoMed Optomedical Systems GmbH, Spectrometrix Optoelectronic Systems GmbH
InventorsJan Hennrik Wilkens, Rolf Stirner
Estimating the term…
The invention relates to an irradiation device and method for the treatment of totally or partially cell-mediated inflammations of the skin, the connective tissue and the viscera, viral and other infectious diseases such as HIV and prionic infections, fungal infections of th skin and the mucous membranes, bacterial diseases of the skin and the mucous membranes as well hand eczema and anal eczema which comprises at least one irradiation device to irradiate a surface treatment area where the wavelength of the emitted radiation to a treatment area is longer than 400 nm and comprises at least one spectral band between 400-500 nm while the radiation device contains means for the generation of optical pulses towards a treatment area with a power density of the optical pulse peaks larger than 0,5 W/cm2 and smaller than 100 kW/cm2 The energy of one pulse relates to 0,05-10 J/cm2.
An irradiation device particularly for the treatment of totally or partially cell mediated inflammations of the skin and the viscera, comprising at least one radiation source for the irradiation of larger areas to be treated, the emitted wavelength on the treatment area being at least 400 nm and comprising a wavelength range of 400-500 nm,
Irradiation device according to any of the preceding claims wherein the radiation source is pulse operable and/or movable in relation to the area to be irradiated.
Irradiation device according to any of the preceding claims wherein said irradiation source is a xenon- or deuterium flashlamp or an overload-pulse operated galliumiodide-doped mercury lamp with a device for the cutting off and/or transformation of the UV parts and other undesired parts of the spectrum within the desired area of the spectrum.
Irradiation device according to any of the preceding claims wherein the pulsed irradiation source has means with wihich it can be made operable in simmer mode.
Irradiation device according to any of the preceding claims wherein said irradiation source is equipped with a cooling device for the area to be irradiated which belongs to the irradiation source and/or the fluorescent foil.
Irradiation device according to any of the preceding claims wherein said irradiation device has means assigned for the topical or inhalative admission of oxygen.
Irradiation device according to any of the preceding claims wherein the irradiation source has additional emission in the range of 520-550 nm and/or 610-670 nm.
Irraditation device according to any of the preceding claims wherein said irradiation source is enclosed by a paraboloid or ellipsoid reflector.
Irradiation device according to any of the preceding claims wherein the beam diameter of the emitted light is at least in one dimension wider than 10 mm and narrower than 100 mm.
Irradiation device characterised by individual or all new features or combination of the disclosed features.
Method particularly for the treatment of totally or partially cell mediated inflammations of the skin, connective tissue and the viscera, in particular atopic dermatitis cutaneous T-cell lymphoma, lichen ruber, alopecia areata, systemic lupus erythematodes, psoriasis and scleroderma, including other connective tissue diseases, multiple sclerosis, uveitis, Morbus Crohn and other diseases with an immunological background, including the treatment of infectious diseases such as herpes,papilloma virus, fungus, HIV, prions and burn wounds and disturbed wound healing through bacterial infection comprising at least one radiation source for the irradiation of larger areas to be treated, the emitted wavelength on the treatment area being at least 400 nm and comprising a wavelength range of 400-500 nm,
Method characterised by individual or all new features or combination of the disclosed features.
Dependencies are inferred from the claim text.